Cardium Therapeutics (CXM)
Cardium Therapeutics Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 0.2383 | 0.24 | 0.2322 | 0.2375 | 99240 |
| May 24, 2012 | 0.2381 | 0.2381 | 0.232 | 0.2381 | 123776 |
| May 23, 2012 | 0.2499 | 0.2499 | 0.23 | 0.2376 | 175348 |
| May 22, 2012 | 0.2386 | 0.244 | 0.2309 | 0.2399 | 85228 |
| May 21, 2012 | 0.24 | 0.24 | 0.2243 | 0.2386 | 221608 |
| May 18, 2012 | 0.23 | 0.245 | 0.221 | 0.2343 | 247341 |
| May 17, 2012 | 0.26 | 0.26 | 0.23 | 0.23 | 200091 |
| May 16, 2012 | 0.26 | 0.26 | 0.2318 | 0.235 | 174302 |
| May 15, 2012 | 0.26 | 0.26 | 0.2418 | 0.245 | 235230 |
| May 14, 2012 | 0.26 | 0.26 | 0.24 | 0.2405 | 272962 |
| May 11, 2012 | 0.235 | 0.275 | 0.235 | 0.249 | 729439 |
| May 10, 2012 | 0.231 | 0.24 | 0.221 | 0.23 | 83948 |
| May 9, 2012 | 0.2176 | 0.2295 | 0.2117 | 0.225 | 215780 |
| May 8, 2012 | 0.215 | 0.22 | 0.215 | 0.2176 | 128518 |
| May 7, 2012 | 0.23 | 0.23 | 0.2021 | 0.22 | 339143 |
| May 4, 2012 | 0.23 | 0.239 | 0.2275 | 0.23 | 184476 |
| May 3, 2012 | 0.2313 | 0.24 | 0.23 | 0.239 | 256915 |
| May 2, 2012 | 0.23 | 0.2395 | 0.23 | 0.237 | 94000 |
| May 1, 2012 | 0.24 | 0.245 | 0.23 | 0.235 | 124137 |
| April 30, 2012 | 0.24 | 0.24 | 0.225 | 0.24 | 155576 |
| April 27, 2012 | 0.231 | 0.245 | 0.2306 | 0.238 | 145221 |
| April 26, 2012 | 0.2352 | 0.244 | 0.225 | 0.2306 | 178668 |
| April 25, 2012 | 0.24 | 0.2442 | 0.2302 | 0.2325 | 130050 |
| April 24, 2012 | 0.245 | 0.2534 | 0.245 | 0.25 | 63394 |
| April 23, 2012 | 0.295 | 0.295 | 0.241 | 0.245 | 438736 |
| April 20, 2012 | 0.23 | 0.2612 | 0.23 | 0.2519 | 709153 |
| April 19, 2012 | 0.23 | 0.2399 | 0.22 | 0.2389 | 256753 |
| April 18, 2012 | 0.2204 | 0.2299 | 0.215 | 0.225 | 387613 |
| April 17, 2012 | 0.2255 | 0.238 | 0.225 | 0.2325 | 266415 |
| April 16, 2012 | 0.215 | 0.249 | 0.215 | 0.2333 | 410399 |
| April 13, 2012 | 0.236 | 0.252 | 0.23 | 0.24 | 240350 |
| April 12, 2012 | 0.25 | 0.25 | 0.235 | 0.24 | 179147 |
| April 11, 2012 | 0.25 | 0.25 | 0.2365 | 0.2425 | 226392 |
| April 10, 2012 | 0.2514 | 0.259 | 0.233 | 0.242 | 810571 |
| April 9, 2012 | 0.231 | 0.256 | 0.231 | 0.255 | 415633 |
| April 5, 2012 | 0.266 | 0.27 | 0.25 | 0.25 | 1494736 |
| April 4, 2012 | 0.265 | 0.279 | 0.265 | 0.27 | 307556 |
| April 3, 2012 | 0.2789 | 0.279 | 0.26 | 0.2715 | 349785 |
| April 2, 2012 | 0.295 | 0.295 | 0.2623 | 0.2789 | 533646 |
| March 30, 2012 | 0.29 | 0.29 | 0.26 | 0.28 | 1174915 |
| March 29, 2012 | 0.285 | 0.285 | 0.275 | 0.284 | 308269 |
| March 28, 2012 | 0.28 | 0.286 | 0.2762 | 0.278 | 197800 |
| March 27, 2012 | 0.276 | 0.289 | 0.275 | 0.2836 | 352281 |
| March 26, 2012 | 0.28 | 0.283 | 0.2705 | 0.2791 | 94881 |
| March 23, 2012 | 0.285 | 0.285 | 0.275 | 0.28 | 75033 |
| March 22, 2012 | 0.279 | 0.2835 | 0.275 | 0.2795 | 275680 |
| March 21, 2012 | 0.289 | 0.289 | 0.2722 | 0.2801 | 70123 |
| March 20, 2012 | 0.284 | 0.30 | 0.277 | 0.2801 | 1753126 |
| March 19, 2012 | 0.27 | 0.282 | 0.27 | 0.2769 | 251360 |
| March 16, 2012 | 0.27 | 0.282 | 0.27 | 0.282 | 291213 |
CXM News
$CXM Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System http://stks.co/3yJh
about 4 days ago by OTCShowcase
about 4 days ago by OTCShowcase
Cardium Therapeutics (CXM) Enters Excellagen Agreement with Angel Biomedical
May 15, 9:09AM Street Insider
May 15, 9:09AM Street Insider
Cardium Presents First Quarter 2012 Financial Results and Recent Developments
May 15, 9:00AM PR Newswire
May 15, 9:00AM PR Newswire
$CXM Growing Footprint in Health Sciences and Regenerative Medicine Space http://stks.co/3nJI
about 17 days ago by MissionIR
about 17 days ago by MissionIR
Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System
May 11, 8:20AM Marketwire
May 11, 8:20AM Marketwire
Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
Apr 19, 6:43PM PR Newswire
Apr 19, 6:43PM PR Newswire
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Apr 02, 8:00AM PR Newswire
Apr 02, 8:00AM PR Newswire
Cardium Presents Fourth Quarter and Year-End 2011 Financial Results and Recent Developments
Mar 30, 9:15AM PR Newswire
Mar 30, 9:15AM PR Newswire
FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit
Mar 19, 8:20AM Marketwire
Mar 19, 8:20AM Marketwire
Cardium Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum
Jan 30, 9:00AM PR Newswire
Jan 30, 9:00AM PR Newswire
Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally
Jan 17, 8:20AM Marketwire
Jan 17, 8:20AM Marketwire
Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines
Jan 03, 9:01AM Benzinga
Jan 03, 9:01AM Benzinga
Cardium Therapeutics (CXM) Enters Into Cross-Strategic Equity Investment Partnership with SourceOne Global Partners
Dec 21, 9:23AM Street Insider
Dec 21, 9:23AM Street Insider
$CXM heavy premarket volume, potential FDA approval would be nice way to finish year
about 517 days ago by CaptainOyama
about 517 days ago by CaptainOyama
$SPY trending higher. Check out $CXM FDA approval coming 12/31 this stock trades at .48 will go to $2 or more on approval.
about 522 days ago by scottheggs
about 522 days ago by scottheggs
What to look forward to June 2010 for investors? $CXM, $HNAB, $DCTH, $QCOR http://goo.gl/fb/GuP5p #europecrisis
about 728 days ago by comparebroker
about 728 days ago by comparebroker
$CXM filled the gap.support at .58. first target .87, next stop 1.03. hope to see u all there.
about 766 days ago by StockTA888
about 766 days ago by StockTA888
but will consider buying in the .40s in $CXM, if it gets back down there.
about 768 days ago by LitheLyricist
about 768 days ago by LitheLyricist
buying programs chewing through offers in $CXM. A big offer is left at .55. Risk/reward not good enough to pay .55, probably
about 768 days ago by LitheLyricist
about 768 days ago by LitheLyricist
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CXM | 0.2375 | -0.00 | -0.25% | 28.41M |
| CXH | 10.60 | +0.00 | +0.00% | |
| CXDC | 4.93 | -0.05 | -1.00% | 234.32M |
| CXA | 24.42 | +0.02 | +0.08% | |
| CX | 5.47 | +0.00 | +0.00% | 5.797B |
| CWTR | 0.84 | +0.02 | +2.44% | 102.15M |
| CVS | 44.98 | -0.19 | -0.42% | 58.77B |
| CVRT | 21.71 | +0.00 | +0.00% | |
| CVR | 18.70 | -0.07 | -0.37% | 18.14M |
| CVO | 1.72 | +0.02 | +1.18% | 109.10M |